The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

The Brugada syndrome is an inherited disorder associated with risk of ventricular fibrillation
and sudden cardiac death in a structurally normal heart. Diagnosis is based on a …

Brugada syndrome (BrS) is an “inherited” condition characterized by predisposition to
syncope and cardiac arrest, predominantly during sleep. The prevalence is∼ 1: 2,000, and …

Objectives The goal of this study was to develop a risk score model for patients with Brugada
syndrome (BrS). Background Risk stratification in BrS is a significant challenge due to the …

BACKGROUND: Brugada syndrome poses significant challenges in terms of risk
stratification and management, particularly for asymptomatic patients who comprise the …

Background: Although large randomized clinical trials have found that primary prevention
use of an implantable cardioverter-defibrillator (ICD) improves survival in patients with …

Brugada syndrome is an inherited disease characterized by an increased risk of sudden
cardiac death owing to ventricular arrhythmias in the absence of structural heart disease …

The diagnosis of Brugada syndrome (BrS) requires the presence of a coved (Type 1) ST
segment elevation in the right precordial leads of the electrocardiogram (ECG). The dynamic …

Background: Guidelines recommend the use of implanted cardioverter-defibrillators in
patients with Brugada syndrome and induced ventricular tachyarrhythmias, but there is no …

Risk stratification in Brugada syndrome remains a clinical challenge because the event rate
is low but the presenting symptom is often cardiac arrest (CA). We review the data on risk …